These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9343212)

  • 1. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
    Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
    J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Staffa A; Cochrane A
    Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
    Si ZH; Rauch D; Stoltzfus CM
    Mol Cell Biol; 1998 Sep; 18(9):5404-13. PubMed ID: 9710624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    Benko DM; Schwartz S; Pavlakis GN; Felber BK
    J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.
    Göttlinger HG; Dorfman T; Cohen EA; Haseltine WA
    Virology; 1992 Aug; 189(2):618-28. PubMed ID: 1641982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function.
    Asai K; Platt C; Cochrane A
    Virology; 2003 Sep; 314(1):229-42. PubMed ID: 14517076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Madsen JM; Stoltzfus CM
    Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
    J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
    Si Z; Amendt BA; Stoltzfus CM
    Nucleic Acids Res; 1997 Feb; 25(4):861-7. PubMed ID: 9016638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.
    Arrigo SJ; Weitsman S; Rosenblatt JD; Chen IS
    J Virol; 1989 Nov; 63(11):4875-81. PubMed ID: 2677405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.
    Verhoef K; Bilodeau PS; van Wamel JL; Kjems J; Stoltzfus CM; Berkhout B
    J Virol; 2001 Apr; 75(7):3495-500. PubMed ID: 11238879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.